Plasma levels of pentraxin 3 in patients with spondyloarthritis.

about

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

Item

http://www.wikidata.org/entity/Q39044356

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

@en

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

@nl

type

Item

label

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

@en

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

@nl

prefLabel

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

@en

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

@nl

P1476

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

@en

P2093

Henrique Rasera

http://www.w3.org/2001/XMLSchema#string

Iara Messias-Reason

http://www.w3.org/2001/XMLSchema#string

João Otávio Zeni

http://www.w3.org/2001/XMLSchema#string

Karita Lidani

http://www.w3.org/2001/XMLSchema#string

Renato Nisihara

http://www.w3.org/2001/XMLSchema#string

Thelma L Skare

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulation

PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.

Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.

Association of Pentraxin 3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis.

The pathogenesis of ankylosing spondylitis.

Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis.

Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.

Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.

Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?

Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1354750X.2016.1278265

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28043168

http://www.w3.org/2001/XMLSchema#string